Rock Springs Capital Management LP Q3 2021 Filing
Filed November 15, 2021
Portfolio Value
$4.8T
Holdings
153
Report Date
Q3 2021
Filing Type
13F-HR
All Holdings (153 positions)
| Stock | Value |
|---|---|
AGLAGILON HEALTH INC | $185.4B |
HUMHUMANA INC | $133.1B |
AFWALIGN TECHNOLOGY INC | $133.1B |
PODDINSULET CORP | $124.4B |
ISRGINTUITIVE SURGICAL INC | $119.3B |
AGIOAGIOS PHARMACEUTICALS INC | $118.0B |
ZLABZAI LAB LTD | $113.6B |
IDXXIDEXX LABS INC | $111.9B |
HCAHCA HEALTHCARE INC | $109.2B |
NBIXNEUROCRINE BIOSCIENCES INC | $100.8B |
ARGXARGENX SE | $95.1B |
NVV1NOVAVAX INC | $94.3B |
UNHUNITEDHEALTH GROUP INC | $93.8B |
IMCRIMMUNOCORE HLDGS PLC | $90.6B |
2L9BLUEPRINT MEDICINES CORP | $87.4B |
HZNPHORIZON THERAPEUTICS PUB L | $76.9B |
FRPTFRESHPET INC | $75.2B |
NVTA1EURINVITAE CORP | $74.1B |
NVROEURNEVRO CORP | $74.0B |
RAREULTRAGENYX PHARMACEUTICAL IN | $72.3B |
ACRSACLARIS THERAPEUTICS INC | $68.5B |
EWEDWARDS LIFESCIENCES CORP | $65.9B |
ASNDASCENDIS PHARMA A/S | $63.8B |
MRTXEURMIRATI THERAPEUTICS INC | $62.5B |
PHRPHREESIA INC | $59.8B |
ALNYALNYLAM PHARMACEUTICALS INC | $58.7B |
EVHEVOLENT HEALTH INC | $58.1B |
PCRXPACIRA BIOSCIENCES INC | $56.0B |
EXASEXACT SCIENCES CORP | $54.4B |
PRTAPROTHENA CORP PLC | $50.6B |
TFXTELEFLEX INCORPORATED | $49.0B |
KRTXKARUNA THERAPEUTICS INC | $47.9B |
ARVNARVINAS INC | $47.5B |
CERE1EURCEREVEL THERAPEUTICS HLDNG I | $47.2B |
SWAVUSDSHOCKWAVE MED INC | $45.3B |
ACHCACADIA HEALTHCARE COMPANY IN | $45.3B |
VERVVERVE THERAPEUTICS INC | $45.3B |
KYMRKYMERA THERAPEUTICS INC | $43.1B |
HCATHEALTH CATALYST INC | $42.5B |
SGENUSDSEAGEN INC | $42.5B |
PENPENUMBRA INC | $39.3B |
ACCDEURACCOLADE INC | $38.9B |
EHCENCOMPASS HEALTH CORP | $37.5B |
TVTXTRAVERE THERAPEUTICS INC | $36.3B |
BAXBAXTER INTL INC | $36.2B |
WRBYWARBY PARKER INC | $34.5B |
GRPHGRAPHITE BIO INC | $34.0B |
—INTERSECT ENT INC | $33.2B |
SRPTSAREPTA THERAPEUTICS INC | $32.4B |
ALLKGUSDALLAKOS INC | $32.4B |
MIRMMIRUM PHARMACEUTICALS INC | $30.4B |
CVETUSDCOVETRUS INC | $29.4B |
IMRXIMMUNEERING CORP | $28.9B |
—SIERRA ONCOLOGY INC | $28.8B |
—MERSANA THERAPEUTICS INC | $28.5B |
CYTK 4 11/15/26CYTOKINETICS INC | $28.3B |
DVAXDYNAVAX TECHNOLOGIES CORP | $27.5B |
AVIRATEA PHARMACEUTICALS INC | $26.3B |
IRTCIRHYTHM TECHNOLOGIES INC | $26.2B |
DC4DEXCOM INC | $25.4B |
LUNGPULMONX CORP | $25.2B |
GHGUARDANT HEALTH INC | $25.0B |
LFSTLIFESTANCE HEALTH GROUP INC | $24.5B |
CGEMCULLINAN ONCOLOGY INC | $24.3B |
ABOSACUMEN PHARMACEUTICALS INC | $23.5B |
—ABCAM PLC | $23.3B |
WHWKAADI BIOSCIENCES INC | $22.5B |
AMRNAMARIN CORP PLC | $22.0B |
—ICOSAVAX INC | $21.7B |
CNMDCONMED CORP | $21.3B |
MDGLMADRIGAL PHARMACEUTICALS INC | $20.9B |
BOLT1EURBOLT BIOTHERAPEUTICS INC | $20.9B |
NVCRNOVOCURE LTD | $20.3B |
BMRNBIOMARIN PHARMACEUTICAL INC | $19.6B |
OSH3EUROAK STR HEALTH INC | $18.8B |
—EPIZYME INC | $18.4B |
COLLCOLLEGIUM PHARMACEUTICAL INC | $17.8B |
RIGLUSDRIGEL PHARMACEUTICALS INC | $17.4B |
SPROSPERO THERAPEUTICS INC | $17.3B |
GOSS 5 06/01/27GOSSAMER BIO INC | $16.3B |
LEGNLEGEND BIOTECH CORP | $15.9B |
—AMRYT PHARMA PLC | $15.6B |
KURAKURA ONCOLOGY INC | $15.4B |
RLAYRELAY THERAPEUTICS INC | $14.8B |
ANABANAPTYSBIO INC | $14.5B |
—PROMETHEUS BIOSCIENCES INC | $14.5B |
—BRIGHT HEALTH GROUP INC | $14.4B |
LPTXEURLEAP THERAPEUTICS INC | $14.1B |
NKTXNKARTA INC | $14.0B |
BMEABIOMEA FUSION INC | $14.0B |
AUPHAURINIA PHARMACEUTICALS INC | $13.6B |
MGNXMACROGENICS INC | $13.4B |
—VINCERX PHARMA INC | $12.9B |
FULCFULCRUM THERAPEUTICS INC | $12.8B |
WSTWEST PHARMACEUTICAL SVSC INC | $12.7B |
AKROAKERO THERAPEUTICS INC | $12.7B |
AGLEUSDAEGLEA BIOTHERAPEUTICS INC | $12.5B |
—OLINK HLDG AB | $12.2B |
RCKTROCKET PHARMACEUTICALS INC | $12.1B |
MREOMEREO BIOPHARMA GROUP PLC | $11.7B |
Page 1 of 2Next